Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery

Recruiting

Phase 2

rEV131Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery

Sponsor:

Evolutec Group

Code:

NCT00353964

Conditions

Ocular Inflammation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

rEV131

Prenisolone sodium phosphate 1.0%

rEV131 vehicle

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Evolutec Group on 2006-07-28.